Antigen transduced T cells used as a delivery system for antigens

Details for Australian Patent Application No. 2003278502 (hide)

Owner MolMed SpA

Inventors Bordignon, Claudio; Traversari, Catia

Agent Wrays

Pub. Number AU-A-2003278502

PCT Number PCT/IB03/05109

PCT Pub. Number WO2004/035768

Priority 0224442.4 21.10.02 GB

Filing date 21 October 2003

Wipo publication date 4 May 2004

International Classifications

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 039/02 Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 039/12 Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 0224442.4 21.10.02 GB

24 June 2004 Application Open to Public Inspection

  Published as AU-A-2003278502

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278503-METHODS FOR PREDICTING THERAPEUTIC RESPONSE TO AGENTS ACTING ON THE GROWTH HORMONE RECEPTOR

2003278501-USE OF POLY-ALPHA2,8-SIALIC ACID MIMETIC PEPTIDES TO MODULATE NCAM FUNCTIONS.